<DOC>
	<DOCNO>NCT01149174</DOCNO>
	<brief_summary>Early single instillation chemotherapy TUR recommend European Association Urology Guidelines . Nevertheless , procedure suboptimal patient multiple tumor , sometimes tolerated result severe complication . In laboratory clinical study , intravesical electromotive drug administration ( EMDA ) increase mitomycin-C ( MMC ) bladder uptake , result improved clinical efficacy non-muscle invasive bladder cancer ( NMIBC ) . The investigator compare effect one immediate pre-TUR intravesical EMDA/MMC instillation one immediate post-TUR intravesical passive diffusion MMC ( PD/MMC ) instillation TUR alone patient NMIBC . All eligible patient primary NMIBC randomize 3 group undergo transurethral resection alone ( TUR/alone ) ; TUR plus single immediate postoperative instillation ( immediately TUR ) 40 mg PD/MMC dwell time 60 minute ; single immediate preoperative instillation ( immediately TUR ) 40 mg EMDA/MMC 20 mA electric current 30 minute . Patients intermediate high risk NMIBC undergo adjuvant intravesical therapy . The primary end point recurrence rate disease-free interval . All clinical analysis perform intent treat basis .</brief_summary>
	<brief_title>Preoperative Intravesical Electromotive Mitomycin-c Primary Non-muscle Invasive Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>All patient primary histologically proven stage pTapT1 transitionalcell carcinoma bladder Previous treatment bacillus CalmetteGuerin , mitomycinC , intravesical cytostatic agent Concomitant urothelial tumour upper urinary tract Previous concomitant muscleinvasive ( ie , stage T2 high ) transitionalcell carcinoma bladder Bladder capacity le 200 ml Untreated urinarytract infection Disease upper urinary tract Previous radiotherapy pelvis Other concurrent chemotherapy Treatment radiotherapyresponse biologicalresponse modifier Other malignant disease within 5 year trial registration ( except basalcell carcinoma ) Pregnancy nursing And psychological , familial sociological factor would preclude study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>intravesical chemotherapy</keyword>
	<keyword>early single instillation</keyword>
	<keyword>mitomycin-C</keyword>
	<keyword>electromotive drug administration</keyword>
</DOC>